Gain Therapeutics
Gain Therapeutics is a developer of pharmacological chaperones drugs designed to treat rare metabolic disorders. The company's drugs utilize Minoryx Direct Enzyme Therapy to identify a new generation of uncomplicated adjuvants, enabling clients to help patients stabilize misfolding mutations and restore protein's enzymatic activity. It targets lysosomal enzymes to develop innovative drugs for rare pediatric genetic disorders and selected CNS diseases with high unmet medical needs. Established in 2017 and is headquartered in Bethesda, MD, USA.
Domain
gaintherapeutics.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$7.0M
Founded
2016
Tech Stack (32 technologies)
Frequently Asked Questions
What technologies does Gain Therapeutics use?+
Gain Therapeutics uses 32 technologies including Elementor, Font Awesome, Google Analytics.
What industry is Gain Therapeutics in?+
Gain Therapeutics operates in the Biotechnology industry.
Where is Gain Therapeutics based?+
Gain Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026